- Home
- UGRO vs TCRT Comparison
UGRO vs TCRT Comparison
Compare UGRO & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- TCRT
- Stock Information
- Founded
- UGRO 2014
- TCRT 1998
- Country
- UGRO United States
- TCRT United States
- Employees
- UGRO N/A
- TCRT N/A
- Industry
- UGRO Industrial Specialties
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- TCRT Health Care
- Exchange
- UGRO Nasdaq
- TCRT Nasdaq
- Market Cap
- UGRO 3.8M
- TCRT 3.8M
- IPO Year
- UGRO N/A
- TCRT N/A
- Fundamental
- Price
- UGRO $0.32
- TCRT $4.99
- Analyst Decision
- UGRO Strong Buy
- TCRT
- Analyst Count
- UGRO 1
- TCRT 0
- Target Price
- UGRO $3.00
- TCRT N/A
- AVG Volume (30 Days)
- UGRO 538.3K
- TCRT 48.8K
- Earning Date
- UGRO 07-22-2025
- TCRT 08-13-2025
- Dividend Yield
- UGRO N/A
- TCRT N/A
- EPS Growth
- UGRO N/A
- TCRT N/A
- EPS
- UGRO N/A
- TCRT N/A
- Revenue
- UGRO $59,985,138.00
- TCRT $11,000.00
- Revenue This Year
- UGRO N/A
- TCRT $5,680,500.00
- Revenue Next Year
- UGRO $31.25
- TCRT N/A
- P/E Ratio
- UGRO N/A
- TCRT N/A
- Revenue Growth
- UGRO N/A
- TCRT 83.33
- 52 Week Low
- UGRO $0.26
- TCRT $1.31
- 52 Week High
- UGRO $1.92
- TCRT $6.90
- Technical
- Relative Strength Index (RSI)
- UGRO 55.26
- TCRT 66.12
- Support Level
- UGRO $0.29
- TCRT $4.72
- Resistance Level
- UGRO $0.34
- TCRT $5.24
- Average True Range (ATR)
- UGRO 0.04
- TCRT 0.46
- MACD
- UGRO 0.01
- TCRT -0.02
- Stochastic Oscillator
- UGRO 49.04
- TCRT 66.89
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.